Survivor Story
Irasema Chavez shares her inspiring story about overcoming stomach cancer and breast cancer in the AACR Cancer Disparities Progress Report 2024.
Irasema's Story and Video
Irasema Chavez shares her inspiring story about overcoming stomach cancer and breast cancer in the AACR Cancer Disparities Progress Report 2024.
Irasema's Story and VideoCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreWhat is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the ReportChildhood rhabdomyosarcoma is the most common type of soft tissue sarcoma in children. July is Sarcoma Awareness Month.
Learn MoreExtending Remissions in Lung Cancer: Researchers are investigating who benefits from immune checkpoint inhibitors and when they should be administered for maximum impact.
Read MoreThe Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through September 3. Registration for new users closed July 10.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
